Traditional Chinese medicine for treating senile cataract

Abstract

The invention relates to a traditional Chinese medicine for treating senile cataract. The medicine is characterized by comprising the following raw materials: 0.2-0.5g of shelled sepium and 0.1-0.4g of borneol. The shelled sepium and the borneol are ground into powder, then 8ml of physiological saline is added to the powder, and an obtained mixture is bottled in an eye drop bottle for standby. When in use, the medicine is uniformly shaken first and then dropped into eyes. A patient can drop 2-3 drops of the medicine each time, and the medicine needs to be dropped for 3-4 times a day. The invention has the advantages that if the medicine is used in an incipient stage, the medicine can increase partial nutrition of lenses and stop the radiation effects of ultraviolet rays and various harmfulsubstances. The medicine has economy, convenience and certain curative effect and is worth popularizing and applying.

Description

technical field [0001] The invention relates to a Chinese herbal medicine formula, in particular to a traditional Chinese medicine for treating senile cataract. Background technique [0002] At present, it is well known that cataract is a common eye disease among middle-aged and elderly people. Its onset process is relatively long, and it is the main disease leading to blindness. The current treatment for this disease is mainly surgical removal, but it must wait until the over-maturity period before performing surgery. , That is to say, the operation can only be performed after the patient is blind. Some patients cannot be operated due to physical and economic reasons, resulting in lifelong blindness, and some patients have unsatisfactory postoperative effects. Contents of the invention [0003] The technical problem to be solved by the present invention is to provide a traditional Chinese medicine for treating senile cataract in order to overcome the deficiencies in the e...

AI Technical Summary

Problems solved by technology

[0002] At present, it is well known that cataract is a common eye disease among middle-aged and elderly people. Its onset process is relatively long, and it is the main disease leading to blindness. The current treatment for this disease is mainly surgical removal, but it must wait until the over-maturity period before performing surgery. , That is to say, the operation can only be performed after the patient is blind. Some patients cannot be operated due to physical and economic reasons, resulting in lifelong blindness. Some patients have unsatisfactory postoperative results